Skip to main content

Table 2 Bone markers and PTH throughot the study period

From: High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis – a randomized controlled trial

  CTX1 (μg/l) PINP (μg/l) PTH pmol/L
Placebo Vitamin D p-value* Placebo Vitamin D p-value* Placebo Vitamin D p-value*
Baseline. mean (SD) 0.20 (0.10) 0.22 (0.11) 0.59 43.10 (15.1) 40.32 (10.0) 0.57 4.75 (1.08) 4.68 (1.29) 0.66
Week 48. mean (SD) 0.22 (0.16) 0.21 (0.11) 0.79 43.36 (17.2) 38.56 (10.6) 0.43 3.68 (1.04) 3.13 (0.96) 0.017
Week 96. mean (SD) 0.23 (0.17) 0.23 (0.12) 0.98 42.54 (15.0) 43.52 (10.6) 0.22 3.96 (1.27) 3.39 (1.00) 0.046
  1. *Obtained from linear mixed model